> The FDA has put Medarex's MDX-010 skin cancer therapy on the agency's fast track. Report
> Johnson & Johnson says that problems experienced by a vendor in distributing drugs for the clinical trials of golimumab for RA will force it to temporarily suspend enrollment in some Phase III studies. J&J says it will resolve the problem quickly. J&J is co-developing the drug with Schering-Plough. Report
> India's Dr. Reddy's is developing a combinational therapy for heart disease. Report
> Basilea Pharmaceutical is exercising its co-promotional option with Cilag on an investigational antibiotic. Report
> WuXi PharmaTech and Merck have agreed to extend and expand an agreement through which WuXi provides a variety of chemistry-related R&D services. Release
> Researcher touts new work on insulin-producing cells. Report
> Scientists find potential Achilles heel in flu virus. Report
> Stem cell transplant may be successful against Parkinson's. Report
And Finally… A string of deaths this year has led some researchers to wonder if marathons are too much of a good thing for runners. Article